If you are looking for a course that is:
brought to you by like-minded people who understand overdiagnosis, overtreatment, and who balance this with their clinical roles
definitely not boring (humour and controversy!)
free of industry sponsorship/conflicts of interest
giving you the “highlights” from a rigorous critical appraisal of the evidence
Then, look no further!
Bupropion? Tramadol?! Lifelong prescriptions to reduce cardiovascular risk? Oseltamivir for prophylaxis?
A loose theme this year is highlighting ‘drugs we’ve continued to use but don’t really understand,’ with some fascinating video illustrations of adverse drug events (ADEs) to keep you on your toes.
Join us for this year’s virtual Bringing Best Evidence to Clinicians from the comfort of your office or home.
Therapeutics Initiative faculty and internationally renowned guest, Dr. John Mandrola, will review best evidence for therapeutic issues important to primary care and specialty medicine.
WHEN: Saturday, October 17th 2020 8:30 AM – 12:30 PM Pacific Daylight Time PDT [UTC -7: convert to your local time]
TARGET AUDIENCE: Family physicians, specialists, pharmacists, nurses, nurse practitioners, allied health professionals, residents & students
COURSE FORMAT: Half-day of plenary talks highlighted by interactive Q&A time
ACCREDITATION: 3.75 Mainpro+ / 3.75 MOC Section 1
REGISTER: https://events.eply.com/bestevidence20 (student and resident rates available; early bird discount before Sept 15)
We promise it won’t be THIS ‘‘cheesy”
AGENDA:
8:30 Welcome and Introductions
8:45 Keynote: Legacy prescriptions for cardiovascular risk reduction (ASA, BB, ACEI, statins): what we know (and don't know) about lifelong
therapy | Dr. John Mandrola
9:50 Informed questions and careful observation will increase your sensitivity to adverse drug effects and help protect your patients | Dr. Tom Perry
10:15 Stretch Break
10:30 We need to talk about tramadol | Dr. Jessica Otte
11:00 Bupropion: the basis for its approval | Dr. Cait O'Sullivan
11:30 A safety net with several holes: Oseltamivir for influenza prophylaxis| Dr. Aaron Tejani
12:00 Summarize Key Messages from the program & Closing Remarks | Dr. Aaron Tejani
12:30 Conference Ends